Table 3.
Variable | Low (n=430 sites) |
Average (n=431 sites) |
High (n=431 sites) |
---|---|---|---|
Unadjusted bleeding rate, % | <4.41 | 4.41–6.23 | ≥6.24 |
Hospital characteristics | |||
Median number of beds (IQR) | 299.5 (182.0, 426.0) | 319.0 (204.0, 469.0) | 321.5 (218.0, 453.0) |
Teaching hospital, % | 33.3 | 41.3 | 44.1 |
Median annual PCI volume, cases (IQR) | 421.9 (215.4, 719.2) | 430.8 (230.8, 692.1) | 310.3 (176.0, 554.8) |
Intraprocedural medications, % | |||
Unfractionated heparin | 45.6 | 51.4 | 60.1 |
Low molecular weight heparin* | 10.7 | 10.5 | 10.7 |
Bivalirudin | 61.8 | 58.3 | 48.4 |
GP IIb/IIIa inhibitor | 24.0 | 30.7 | 39.5 |
Clopidogrel* | 72.1 | 73.3 | 73.6 |
Prasugrel* | 14.9 | 15.1 | 14.4 |
Radial access,* % | 9.8 | 9.4 | 7.2 |
Vascular closure device,* % | 47.8 | 44.3 | 46.4 |
Use of any BAS, % | 83.4 | 79.2 | 74.6 |